Marshall Wace
GOSS icon

Marshall Wace’s Gossamer Bio GOSS Stock Holding History

Marshall Wace’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,713,655
Closed -$1.89M – 2883
2025
Q1 		$1.89M Sell
1,713,655
-820,723
-32% -$949K ﹤0.01% 1489
2024
Q4 		$2.28M Sell
2,534,378
-950,554
-27% -$814K ﹤0.01% 1382
2024
Q3 		$3.45M Buy
3,484,932
+149,421
+4% +$144K ﹤0.01% 1146
2024
Q2 		$3M Buy
3,335,511
+2,103,766
+171% +$1.57M ﹤0.01% 1197
2024
Q1 		$1.45M Buy
1,231,745
+215,962
+21% +$238K ﹤0.01% 1504
2023
Q4 		$924K Sell
1,015,783
-631,032
-38% -$466K ﹤0.01% 1502
2023
Q3 		$1.37M Sell
1,646,815
-104,300
-6% -$120K ﹤0.01% 1386
2023
Q2 		$2.1M Sell
1,751,115
-19,298
-1% -$24K ﹤0.01% 1383
2023
Q1 		$2.23M Buy
1,770,413
+754,963
+74% +$1.45M ﹤0.01% 1396
2022
Q4 		$2.2M Buy
1,015,450
+515,894
+103% +$4.25M 0.01% 1683
2022
Q3 		$5.99M Buy
499,556
+151,805
+44% +$1.88M 0.01% 1242
2022
Q2 		$2.91M Sell
347,751
-224,321
-39% -$1.74M 0.01% 1740
2022
Q1 		$4.96M Hold
572,072
– – 0.01% 1368
2021
Q4 		$6.47M Buy
572,072
+552,820
+2,871% +$6.57M 0.01% 1177
2021
Q3 		$242K Hold
19,252
– – ﹤0.01% 2731
2021
Q2 		$156K Hold
19,252
– – ﹤0.01% 2488
2021
Q1 		$178K Sell
19,252
-12,424
-39% -$125K ﹤0.01% 2292
2020
Q4 		$306K Sell
31,676
-6,683
-17% -$65.8K ﹤0.01% 1647
2020
Q3 		$476K Buy
+38,359
New +$509K ﹤0.01% 1260

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Marshall Wace's GOSS Position: Q2 2025 in Review

Marshall Wace sold out of Gossamer Bio (GOSS) in Q2 2025, closing a stake of 1,713,655 shares — an estimated $1.89M sold.

Marshall Wace first reported a position in GOSS in Q3 2020 and held it in 19 quarters. The position peaked at $6.47M in Q4 2021. 123 funds tracked by Wall St. Rank hold GOSS as of Q2 2025.

  • Marshall Wace reported no remaining Gossamer Bio position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 1,713,655 Gossamer Bio shares in Q2 2025, an estimated $1.89M.
  • Marshall Wace first reported a position in Gossamer Bio in Q3 2020 and held it in 19 quarters.
  • Marshall Wace's Gossamer Bio position peaked at $6.47M in Q4 2021.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.